COMPARISONOF EFFICACY OF MISOPROSTOL VS TRANEXAMIC ACID IN REDUCING INTRAOPERATIVE BLOOD LOSS IN MYOMECTOMY
Keywords:
Blood loss, Misoprostol, Tranexamic acid, MyomectomyAbstract
Objective: Comparison of efficacy of Misoprostol vs Tranexamic acid in reducing intraoperative blood loss in myomectomy.
Material & Methods: This was a prospective comparative study, conducted in Gynae “B” Unit MTI-Lady Reading
Hospital Peshawar-Pakistan from Jan 2018 to Dec 2018 including fifty cases of fibroid uterus undergoing abdominal
myomectomy. Twenty five cases were given misoprostol while other twenty five received Tranexamic acid preoperatively,
by consecutive sampling. Women included in the study had fibroid uterus size ranging from 6-16 cm. These
were all single intramural fibroids. Women with multiple fibroids, size more than 16 cm and those having submucosal
or subserosal fibroid were excluded.
Results: Fifty women were included in the study who had single intramural fibroid with size ranging from 6-16 cm.
Group A received 400 mcg Misoprostol per vaginal, I hour before surgery, and Group B received intravenous Tranexamic
acid during the course of surgery. Mean age was 28.68 years in both groups. No significant difference was observed
in sosciodemographic data in two groups. Intraoperative blood loss was significantly reduced in Misoprostol group (
P< 0.014) with mean difference of blood loss of 171.092 ml compared to Tranexamic acid. There was no significant
difference concerning the duration of surgery, fall in haemoglobin level and need of blood transfusion.
Conclusion: Good clinical outcome, easy to use and minimal side effects proves Misoprostol to be useful in reducing
blood loss in myomectomy.
Downloads
Published
How to Cite
Issue
Section
License
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.
